US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
DarioHealth Corp. - Common Stock
(NQ:
DRIO
)
5.800
-0.660 (-10.22%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DarioHealth Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
March 21, 2022
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.
Via
Benzinga
Earnings Scheduled For March 21, 2022
↗
March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...
Via
Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
↗
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
DarioHealth Earnings Preview
↗
March 18, 2022
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
DarioHealth Announces Two New Contracts within the Employer Market
↗
January 06, 2022
Dario's new employer clients include a contract for its full suite of digital therapeutic solutions.
Via
Talk Markets
Recap: DarioHealth Q3 Earnings
↗
November 15, 2021
DarioHealth (NASDAQ:DRIO) reported its Q3 earnings results on Monday, November 15, 2021 at 04:30 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q4 and Full Year 2021 Results
March 14, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 11, 2022
Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.
Via
Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Two New Contracts to Growing Number of Clients
March 09, 2022
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Cowen Healthcare Conference
March 07, 2022
Via
Investor Brand Network
DarioHealth Signs Multi-Year $30 Million-Dollar Deal With Sanofi U.S., Partnership To Increase Sales Reach In the Health Plan Market
↗
March 01, 2022
Image sourced from Pixabay This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. DarioHealth...
Via
Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Direct Offering Pricing, Inks Agreement with Sanofi US
March 01, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
March 01, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3...
Via
Benzinga
DarioHealth Enters Into Strategic Agreement With Sanofi U.S.
↗
March 01, 2022
Novel Strategic Agreement focuses on commercial growth for Dario and the development of Digital Health Solutions on Dario’s platform.
Via
Talk Markets
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Learnings from Single DTx Platform Approach to Chronic Condition Management
February 09, 2022
Via
Investor Brand Network
DarioHealth Expands Further Into Digital Musculoskeletal Market With PhysiMax Acquisition
↗
February 09, 2022
Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Four New Employer Contracts, Clients Now Number 40+
February 08, 2022
Via
Investor Brand Network
This AI-Driven, Hyper-Personalized App Wants To Be The SaaS Of Healthcare
↗
February 02, 2022
Image provided by Pexels This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Many software...
Via
Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Strategic Move to Acquire Physimax Technologies
January 20, 2022
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with Leading Regional Health Plan
January 19, 2022
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Host Jan. 19 Investor Webinar on Navigating Emerging Digital Health Trends
January 18, 2022
Via
Investor Brand Network
This AI-Powered Health App Reports Helping 200,000+ Users Manage Diabetes, Hypertension, and Other Chronic Health Conditions
↗
January 10, 2022
Image provided by Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. As healthcare...
Via
Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures New Contracts in the Employer Market
January 06, 2022
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Selected as Exclusive DTx Provider to Leading Benefits Brokerage
December 21, 2021
Via
Investor Brand Network
Latest Tech Key in Helping Solve Healthcare's Largest Pain Point
↗
December 07, 2021
NetworkNewsWire Editorial Coverage: Keeping up with precise documentation and a myriad of regulations is not only burdensome for physicians, but it also restricts important...
Via
Benzinga
Latest Tech Key in Helping Solve Healthcare’s Largest Pain Point
December 07, 2021
NetworkNewsWire Editorial Coverage New York, NY – December 7, 2021 – Keeping up with precise documentation and a myriad of regulations is not only burdensome for physicians, it also restricts important...
Via
FinancialNewsMedia
Latest Tech Key in Helping Solve Healthcare’s Largest Pain Point
December 07, 2021
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Achieves Key Milestone to Secure More than 50 Signed Clients
December 02, 2021
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds to Growing List of Employer Contracts
November 18, 2021
Via
Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 Finance, Business Report
November 16, 2021
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
Next >
